Cite

HARVARD Citation

    Claridge, S. et al. (2017). Substrate‐dependent risk stratification for implantable cardioverter defibrillator therapies using cardiac magnetic resonance imaging: The importance of T1 mapping in nonischemic patients. Journal of cardiovascular electrophysiology. pp. 785-795. [Online]. 
  
Back to record